Award

National Cancer Institute 3R01CA286069-02S1

Using gene expression to identify patients at high risk for late breast cancer recurrence

Recipient

Not specified

Award Amount

$204,071.00

Ceiling

$204,071.00

Awarded

September 18, 2024

Identifier

3R01CA286069-02S1

NIH grant awarded by the National Cancer Institute to develop gene expression profiles for predicting late breast cancer recurrence risk using machine learning and biological pathway analysis.

Description

This is a NIH grant project focused on developing a gene expression profile to predict late breast cancer recurrence risk, involving advanced machine learning models and biological pathway analysis.

View original record